Jenny Delfin
Cardiovascular Disease · New York, NYNPI 1033141346
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 84 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Johnson & Johnson at 29.8% of the total. Reporting peaked in 2021 at $450 and has fallen 62.3% since, to $170 in 2025. That places this record below the midpoint for cardiovascular disease clinicians in NY, where the typical reported total is $1,486.
Across 84 payments — averaging $20.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$503
- Novartis$220
- Boston Scientific$165
- Boehringer Ingelheim$162
- Amgen$150
- Merck$86
- plus $404 from 13 others
What the payments were for
- Food & beverage$1,691100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 31 | $503 |
| Novartis | 11 | $220 |
| Boston Scientific | 7 | $165 |
| Boehringer Ingelheim | 7 | $162 |
| Amgen | 6 | $150 |
| Merck | 4 | $86 |
| E.r. Squibb & Sons, L.L.C. | 4 | $65 |
| Kestra Medical Technology Services, Inc. | 2 | $63 |
| Atricure, Inc. | 1 | $50 |
| Heartflow, Inc. | 2 | $41 |
| Viiv Healthcare Company | 1 | $27 |
| Amarin Pharma, Inc. | 1 | $25 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $23 |
| Lexicon Pharmaceuticals, Inc. | 1 | $21 |
| Abbott | 1 | $19 |
| Alnylam Pharmaceuticals Inc. | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Irhythm Technologies, Inc. | 1 | $18 |
| Bardy Diagnostics, Inc. | 1 | $16 |
How this compares
$1,691 in reported general payments places this provider in the 50th percentile of 2,302 cardiovascular disease providers in New York.
Other cardiovascular disease in New York
- Roger HajjarNew York$5.2M
- Gregg StoneNew York$2M
- Philippe GenereuxNew York$1.3M
- Adam RosenbluthNew York$1.1M
- Megha PrasadNew York$813K
- Eyal HerzogNew York$645K
- Nisha JhalaniNew York$443K
- Roxana MehranNew York$432K
- Howard WeintraubNew York$328K
- Anuradha Lala-TrindadeNew York$324K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.